Boston Scientific to appeal $11 million patent suit
This article was originally published in Clinica
Executive Summary
CR Bard has been awarded damages of $10.8 million in a patent infringement it filed against Boston Scientific over the latter's esophageal dilation catheter, MaxForce TTS.